Chemo-refractory Melanoma
1 clinical trials · Condition
◉ Watch Chemo-refractory Melanoma
| Record | Firm | Date |
|---|---|---|
| Trial of Single Agent Sunitinib for Patients With Chemo-refractory Metastatic Melanoma (NCT01216657) | Krankenhaus Nordwest | 2009-03-01 |
Track Chemo-refractory Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.